FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer
CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints
ODAC Reviews Post-Marketing Studies for Eight Indications
Georgetown Sponsors Oncology Agent Development Meeting
Bush Appoints Kripke To President’s Cancer Panel
Letter to the Editor
Trending Stories
- U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage data
Rankings now include a list of Best Regional Hospitals for Equitable Access - Robert Gallo named founding director of Microbial Oncology Program at TGH Cancer Institute
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Proposed rule by CMS would expand access to cancer treatment at tribal facilities
- Platinum drugs are off the shortage list, but the underlying problem is unsolved
FDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.” - A view from the BMT unit on the day a Russian cruise missile hit Kyiv’s Ohmatdyt hospital